Database : MEDLINE
Search on : Vasculitis [Words]
References found : 35158 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 3516 go to page                         

  1 / 35158 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 26971201
[Au] Autor:Chaigne B; Dion J; Guillevin L; Mouthon L; Terrier B
[Ad] Address:Inserm, U1016, institut Cochin, Paris, France; CNRS, UMR8104, Paris, France; Faculté de médecine, université Paris Descartes, département de médecine interne, centre de référence pour les vascularites nécrosantes et la sclérodermie systémique, hôpital Cochin, Assistance publique-Hôpitaux de Paris, P...
[Ti] Title:Physiopathologie de la granulomatose éosinophilique avec polyangéite (Churg-Strauss). [Pathophysiology of eosinophilic granulomatosis with polyangitis (Churg-Strauss)].
[So] Source:Rev Med Interne;37(5):337-42, 2016 May.
[Is] ISSN:1768-3122
[Cp] Country of publication:France
[La] Language:fre
[Ab] Abstract:Eosinophilic granulomatosis with polyangitis (EGPA) (formerly Churg-Strauss syndrome) is a rare small-sized vessel vasculitis belonging to the group of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitides. MPO-ANCA is present in only 31 to 38% of patients. In this review, we describe the pathophysiology of EGPA, which is characterized by a genetic predisposition, an environmental association, and a cellular dysfunction of eosinophils, neutrophils, and T and B cells.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[St] Status:In-Data-Review

  2 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 26644039
[Au] Autor:Fillâtre P; Revest M; Belaz S; Robert-Gangneux F; Zahar JR; Roblot F; Tattevin P
[Ad] Address:Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, CHU de Rennes, 35033 Rennes, France....
[Ti] Title:Pneumocystose chez les patients immunodéprimés non infectés par le VIH. [Pneumocystosis in non-HIV-infected immunocompromised patients].
[So] Source:Rev Med Interne;37(5):327-36, 2016 May.
[Is] ISSN:1768-3122
[Cp] Country of publication:France
[La] Language:fre
[Ab] Abstract:Pneumocystis jiroveci (formerly P. carinii) is an opportunistic fungus responsible for pneumonia in immunocompromised patients. Pneumocystosis in non-HIV-infected patients differs from AIDS-associated pneumocystosis in mostly two aspects: diagnosis is more difficult, and prognosis is worse. Hence, efforts should be made to target immunocompromised patients at higher risk of pneumocystosis, so that they are prescribed long-term, low-dose, trimethoprime-sulfamethoxazole, highly effective for pneumocystosis prophylaxis. Patients at highest risk include those with medium and small vessels vasculitis, lymphoproliferative B disorders (chronic or acute lymphocytic leukaemia, non-Hodgkin lymphoma), and solid cancer on long-term corticosteroids. Conversely, widespread use of prophylaxis in all patients carrier of inflammatory diseases on long-term corticosteroids is not warranted. The management of pneumocystosis in non-AIDS immunocompromised patients follows the rules established for AIDS patients. The diagnosis relies on the detection of P. jiroveci cyst on respiratory samples, while PCR does not reliably discriminate infection from colonization, in 2015. High-doses trimethoprim-sulfamethoxazole is, by far, the treatment of choice. The benefit of adjuvant corticosteroid therapy for hypoxic patients, well documented in AIDS patients, has a much lower level of evidence in non-HIV-infected patients, most of them being already on corticosteroid by the time of pneumocystosis diagnosis anyway. However, based on its striking impact on morbi-mortality in AIDS patients, adjuvant corticosteroid is recommended in hypoxic, non-HIV-infected patients with pneumocystosis by many experts and scientific societies.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[St] Status:In-Data-Review

  3 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 27095010
[Au] Autor:Butt SU; McNeil J
[Ad] Address:Department of Medicine, Lyell McEwin Hospital, Elizabeth Vale, SA, 5112, Australia. drsabeehurrehman@yahoo.com.
[Ti] Title:Complete heart block in a Caucasian woman with Behçet's disease: a case report.
[So] Source:J Med Case Rep;10(1):102, 2016.
[Is] ISSN:1752-1947
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Behçet's disease is a progressive diffuse inflammatory vasculitis characterized by recurrent oral and genital ulceration and ocular inflammation. Cardiac involvement is a rare but well-documented manifestation of Behçet's disease. Complete heart block in non-Caucasian populations has been reported previously; however, in this report, we describe a unique case of complete heart block in a Caucasian woman with Behçet's disease. CASE PRESENTATION: A 48-year-old Caucasian woman presented to our hospital with symptomatic complete heart block requiring a pacemaker implant on a background of recurrent oral and genital ulcers and oligoarthritis of 10 months' duration. She also had a history of recurrent diarrhea with a single episode of ocular inflammation in the recent past. She had no evidence of cardiac ischemia, and her autoimmune antibodies were within normal ranges. She was diagnosed with Behçet's disease according to international study group criteria and was commenced on prednisolone and sulfasalazine, to which she responded very well. CONCLUSIONS: Cardiac complications should be considered when making a diagnosis of Behçet's disease, even in Caucasian patients. While mucocutaneous ulceration is indeed the most common manifestation of Behçet's disease, cardiovascular involvement tends to cause the most morbidity and mortality.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1604
[Cu] Class update date: 160422
[Lr] Last revision date:160422
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1186/s13256-016-0890-y

  4 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 27031957
[Au] Autor:Luo C; Yao X; Li J; He B; Liu Q; Ren H; Liang F; Li M; Lin H; Peng J; Yuan TF; Pei Z; Su H
[Ad] Address:State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China....
[Ti] Title:Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control.
[So] Source:Cell Death Dis;7:e2160, 2016.
[Is] ISSN:2041-4889
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:Subarachnoid hemorrhage (SAH) is a devastating disease with high mortality. The mechanisms underlying its pathological complications have not been fully identified. Here, we investigate the potential involvement of the glymphatic system in the neuropathology of SAH. We demonstrate that blood components rapidly enter the paravascular space following SAH and penetrate into the perivascular parenchyma throughout the brain, causing disastrous events such as cerebral vasospasm, delayed cerebral ischemia, microcirculation dysfunction and widespread perivascular neuroinflammation. Clearance of the paravascular pathway with tissue-type plasminogen activator ameliorates the behavioral deficits and alleviates histological injury of SAH. Interestingly, AQP4(-/-) mice showed no improvements in neurological deficits and neuroinflammation at day 7 after SAH compared with WT control mice. In conclusion, our study proves that the paravascular pathway dynamically mediates the pathological complications following acute SAH independently of glymphatic control.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1604
[Cu] Class update date: 160422
[Lr] Last revision date:160422
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1038/cddis.2016.63

  5 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24008031
[Au] Autor:Velarde-Domínguez T; Pantoja-Alcantar JM; Martínez-Sáenz NP
[Ad] Address:SubsecciÛn de AlergologÌa Pedi·trica de la Unidad de Especialidades MÈdicas, Av Industria Militar 1088, Naucalpan 53960, Estado de MÈxico, MÈxico. velarde1964@hotmail.com.
[Ti] Title:Urticaria aguda asociada con el tratamiento con omalizumab en pacientes con asma infantil. An·lisis de un caso clÌnico. [Acute urticaria associated to omalizumab treatment in a child with asthma].
[So] Source:Rev Alerg Mex;59(4):209-13, 2012 Oct-Dec.
[Is] ISSN:0002-5151
[Cp] Country of publication:Mexico
[La] Language:spa
[Ab] Abstract:Omalizumab is a monoclonal anti-IgE antibody indicated as an adjuvant therapy in moderate persistent allergic asthma in the United States or severe asthma in Europe. In 2009 the European Medicine Agency approved its indication in patients older than six years. In clinical practice, it is considered a safe drug, however local reactions at the injection site, anaphylaxis, or delayed diagnosis of Churg-Strauss syndrome are warned. We report the case of an 8 year-old female patient diagnosed with moderate persistent allergic asthma, who met the criteria for treatment with omalizumab. During the initial injection the patient had erythema and wheal at the site of injection, and presented generalized and fluctuating urticarial within 24 hrs, with partial response to antihistamines. During her second injection, a half of the initial dose was given, and she presented a wheal and flare locally, accompanied by headache, dizziness, sweating, pallor, without loss of consciousness. She has continued receiving this medication, without adverse reactions. It is important to evaluate other substances included in the omalizumab vial, since some of them, as histidine, may be the causative factor of adverse effects.
[Mh] MeSH terms primary: Asthma
55972
[Mh] MeSH terms secundary: Antibodies, Monoclonal, Humanized
Asthma/immunology
Child
Churg-Strauss Syndrome
Humans
Urticaria/drug therapy
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Name of substance:0 (Antibodies, Monoclonal, Humanized); 2P471X1Z11 (Omalizumab)
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130906
[St] Status:MEDLINE

  6 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24007962
[Au] Autor:Gracia-Ramos AE; Vera-Lastra OL
[Ad] Address:Departamento de Medicina Interna, Hospital General Dr Gaudencio Gonz·lez Garza, Centro MÈdico Nacional La Raza, IMSS, Av Jacarandas s/n, colonia La Raza, MÈxico, D.F. ken_monsters@hotmail.com.
[Ti] Title:Síndromes reumáticos paraneoplásicos. [Paraneoplastic rheumatic syndromes].
[So] Source:Rev Alerg Mex;59(2):72-8, 2012 Apr-Jun.
[Is] ISSN:0002-5151
[Cp] Country of publication:Mexico
[La] Language:spa
[Ab] Abstract:Paraneoplastic rheumatic syndromes are defined as those events associated with cancer that occur away from the primary tumor or its metastases and are induced by the presence of the tumor through biological products like hormones, peptides, autocrine or paracrine mediators, antibodies or cytotoxic lymphocytes. Of these, hypertrophic osteoarthropathy, carcinomatous polyarthritis, dermatomyositis/polymyositis, and paraneoplastic vasculitis are the most frequently recognized. Other less known associations are based upon a smaller number of case reports, and include palmar fasciitis, panniculitis, erythema nodosum, Raynaud¥s phenomenon, erythromelalgia and Lupus-like syndrome. Usually the clinical course of rheumatic paraneoplastic syndrome and cancer parallels the resolution of the tumor usually leads to resolution of this syndrome. It is difficult make the distinction between idiopathic rheumatic syndromes from those that result from cancer. Still, there are several clinical data that can guide us to the presence of an occult malignancy, and should be identified as the detection of cancer can lead to early treatment and better prognosis.
[Mh] MeSH terms primary: Paraneoplastic Syndromes
Rheumatic Diseases
[Mh] MeSH terms secundary: Dermatomyositis
Fasciitis
Humans
Osteoarthropathy, Secondary Hypertrophic
Syndrome
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130906
[St] Status:MEDLINE

  7 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24007933
[Au] Autor:Staines-Boon AT; Domínguez-Sansores LA; Sánchez-Sánchez LM; Amaya-Guerra M; González-Cabello D; Danielian S
[Ad] Address:Departamento de EducaciÛn MÈdica e InvestigaciÛn, Unidad MÈdica de Alta Especialidad 25, IMSS, Avenida Lincoln y Fidel Vel·zquez, colonia Nuevo Morelos, Monterrey 64180, NL, MÈxico.
[Ti] Title:Síndrome de Wiskott Aldrich asociado con vasculitis: un desafÌo terapéutico. [Wiskott Aldrich syndrome associated to vasculitis: a therapeutic challenge].
[So] Source:Rev Alerg Mex;59(1):41-5, 2012 Jan-Mar.
[Is] ISSN:0002-5151
[Cp] Country of publication:Mexico
[La] Language:spa
[Ab] Abstract:Wiskott Aldrich syndrome (WAS) is an X-linked primary immunodeficiency, associated with WASP gene mutation that causes severe immunological abnormalities and alterations in platelet function. A seven year old male patient with WASP, began with acute abdominal pain, fever and knee swelling. The diagnosis of septic arthritis was made, and he was treated with broad-spectrum antibiotics and human gammaglobulin. During treatment he presented digestive tract bleeding with hypovolemic shock; after 72 hours palpable purpura in upper and lower extremities appeared. Then Henoch-Schönlein purpura with abdominal vasculitis was suspected, and later confirmed by histopathology. Methylprednisolone pulses were initiated, showing improvement within 24 hours. The patient had a severe inflammatory reaction, caused by a serious infectious disease, but the clinical evolution suggested an autoimmune disease such as Henoch-Schönlein purpura. Up to 20% of patients with WAS have autoimmune manifestations of vasculitis. An early diagnosis of autoimmunity in WAS is important for a favorable clinical outcome.
[Mh] MeSH terms primary: Purpura, Schoenlein-Henoch
Wiskott-Aldrich Syndrome
[Mh] MeSH terms secundary: Abdominal Pain
Humans
Vasculitis
X-Linked Combined Immunodeficiency Diseases
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130906
[St] Status:MEDLINE

  8 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24007932
[Au] Autor:Gámez-González LB; Rodríguez-Lozano A; Rivas-Larrauri F; Yamazaki-Nakashimada MA
[Ad] Address:Servicio InmunologÌa ClÌnica, Instituto Nacional de PediatrÌa, Insurgentes Sur 3700-C, MÈxico 04530 D.F. luibere@hotmail.com.
[Ti] Title:Enfermedad de Kawasaki y pË™rpura de Henoch-Schˆnlein: vasculitis frecuentes en una asociaciÛn infrecuente. [Kawasaki Disease and Henoch-Schönlein Purpura: Frequent Vasculitis in an Infrequent Association].
[So] Source:Rev Alerg Mex;59(1):37-40, 2012 Jan-Mar.
[Is] ISSN:0002-5151
[Cp] Country of publication:Mexico
[La] Language:spa
[Ab] Abstract:Henoch-Schönlein Purpura (HSP) and Kawasaki disease (KD) are the most frequent systemic vasculitis in childhood. Both diseases are clearly distinct and easily distinguishable. Despite their high frequency, the coexistence of both diseases in the same patient is very rare. The diagnosis of these two diseases is based on clinical features, but sometimes it may be difficult, since signs and symptoms can be atypical and occasionally there are overlapping features among different forms of vasculitis. We present a 5 year-old boy who showed KD and three years later he developed HSP. We discuss similarities and differences between these two systemic vasculitic diseases and make a review of the literature of the few cases reported where KD and PHS have coexisted. Although rare, these two diseases can be present in the same patient and should be treated accordingly.
[Mh] MeSH terms primary: Mucocutaneous Lymph Node Syndrome
Purpura, Schoenlein-Henoch
[Mh] MeSH terms secundary: Humans
Systemic Vasculitis
Vasculitis
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130906
[St] Status:MEDLINE

  9 / 35158 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23466848
[Au] Autor:Zhang ZQ; Tian D
[Ad] Address:Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Chongwen District, Beijing 100050, China.
[Ti] Title:Central nervous system vasculitis associated with linear scleroderma.
[So] Source:Neurol India;61(1):78-80, 2013 Jan-Feb.
[Is] ISSN:0028-3886
[Cp] Country of publication:India
[La] Language:eng
[Mh] MeSH terms primary: Scleroderma, Localized
Vasculitis, Central Nervous System
[Mh] MeSH terms secundary: Cerebral Angiography
Humans
Vasculitis
[Pt] Publication type:LETTER
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130307
[St] Status:MEDLINE
[do] DOI:10.4103/0028-3886.108019

  10 / 35158 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 23439289
[Au] Autor:Yakhchali M; Tehrani AA
[Ad] Address:Urmia University Parasitology Division, Department of Pathobiology, Faculty of Veterinary Medicine Nazlu Campus Urmia City P.O. Box 57153-1177 Iran.
[Ti] Title:Histopathological changes caused by the nymph stage of Linguatula serrata in the mesenteric lymph nodes of goats.
[So] Source:Acta Vet Hung;61(1):36-41, 2013 Mar.
[Is] ISSN:0236-6290
[Cp] Country of publication:Hungary
[La] Language:eng
[Ab] Abstract:Linguatula serrata (Fröhlich, 1789) is a ubiquitous parasite species belonging to pentastomids, which has been reported frequently from domestic herbivores of Iran. This study was carried out to elucidate the pathological changes caused by the nymphal stage of L. serrata in the mesenteric lymph nodes (MLNs) of goats. Jejunal and ileal MLNs of slaughtered goats infected with L. serrata were collected and fixed in 10% neutral formal saline. Histopathological changes included follicular necrosis accompanied by a loss of lymphocytes and oedematous cystlike spaces. Granulomatous lesions were formed by mononuclear cell infiltration and necrotic tissue. Some lymphocytes were apoptotic with chromatolysis. A more frequent vascular abnormality was vasculitis. These findings show that larval migration is the main factor to initiate trauma and cause irritation in the MLNs of goats. Since goats are habitual intermediate hosts in Iran, rigorous inspection of the MLNs of slaughtered goats is recommended in order to decrease the chance of human infection through the consumption of raw visceral organs of goats.
[Mh] MeSH terms primary: Goats
Pentastomida
[Mh] MeSH terms secundary: Animals
Humans
Lymph Nodes
Nymph
Parasitic Diseases, Animal/parasitology
Prevalence
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1604
[Js] Journal subset:IM
[Da] Date of entry for processing:130226
[St] Status:MEDLINE
[do] DOI:10.1556/AVet.2012.056


page 1 of 3516 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information